메뉴 건너뛰기




Volumn 8, Issue 7, 2013, Pages 1138-1160

Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) Reductase in Toxoplasma gondii

(18)  Stec, Jozef a,h   Fomovska, Alina b,i   Afanador, Gustavo A c   Muench, Stephen P d   Zhou, Ying b   Lai, Bo Shiun b   El Bissati, Kamal b   Hickman, Mark R e   Lee, Patty J e   Leed, Susan E e   Auschwitz, Jennifer M e   Sommervile, Caroline f   Woods, Stuart f   Roberts, Craig W f   Rice, David g   Prigge, Sean T c   Mcleod, Rima b   Kozikowski, Alan P a  


Author keywords

Enoyl reductase; Inhibitors; Medicinal chemistry; Toxoplasma gondii; Triclosan

Indexed keywords

1 [4 (2,4 DICHLOROPHENOXY) 3 HYDROXYPHENYL]PROPAN 1 ONE; 1 [4 (2,4 DICHLOROPHENOXY) 3 METHOXYBENZYL] 4 (TRIMETHYLSILYL) 1H 1,2,3 TRIAZOLE; 1 [4 (2,4 DICHLOROPHENOXY) 3 METHOXYBENZYL] 4 PHENYL 1H 1,2,3 TRIAZOLE; 2 (2,4 DICHLOROPHENOXY) 5 (1H 1,2,3 TRIAZOL 1 YL METHYL)PHENOL; 2 (2,4 DICHLOROPHENOXY) 5 (5 PHENYL 1,2 OXAZOL 3 YL)PHENOL; 2 (2,4 DICHLOROPHENOXY) 5 [(4 PHENYL 1H 1,2,3 TRIAZOL 1 YL)METHYL]PHENOL; 2 (2,4 DICHLOROPHENOXY) 5 [(HEXYLAMINO)METHYL]PHENOL; 2 (2,4 DICHLOROPHENOXY) 5 [(PHENYLAMINO)METHYL]PHENOL; 2 (2,4 DICHLOROPHENOXY) 5 [5 (TRIMETHYLSILYL) 1,2 OXAZOL 3 YL]PHENOL; 2 [1 [4 (2,4 DICHLOROPHENOXY) 3 METHOXYBENZYL] 1H 1,2,3 TRIAZOL 4 YL]ETHANOL; 2 [1 [4 (2,4 DICHLOROPHENOXY) 3 METHOXYBENZYL] 1H 1,2,3 TRIAZOLE 4 YL]ETHANOL; 2 [4 (5 BUTYL 1,2 OXAZOL 3 YL) 2 CHLOROPHENOXY] 5 CHLOROPHENOL; 2 [4 [(4 BUTYL 1H 1,2,3 TRIAZOL 1 YL)METHYL] 2 CHLOROPHENOXY] 5 CHLOROPHENOL; 4 (2,4 DICHLOROPHENOXY) 3 HYDROXY N PHENYLBENZAMIDE; 4 (2,4 DICHLOROPHENOXY) 3 HYDROXY N,N DIBUTYLBENZAMIDE; 4 (2,4 DICHLOROPHENOXY) 3 HYDROXYBENZONITRILE; 5 (5 BUTYL 1,2 OXAZOL 3 YL) 2 (2,4 DICHLOROPHENOXY)PHENOL; 5 CHLORO 2 [2 CHLORO 4 (5 PHENYL 1,2 OXAZOL 3 YL)PHENOXY]PHENOL; 5 CHLORO 2 [2 CHLORO 4 [(1H 1,2,3 TRIAZOL 1 YL)METHYL]PHENOXY]PHENOL; 5 CHLORO 2 [2 CHLORO 4 [(4 HENYL 1H 1,2,3 TRIAZOL 1 YL)METHYL]PHENOXY]PHENOL; 5 CHLORO 2 [2 CHLORO 4 [(HEXYLAMINO)METHYL]PHENOXY]PHENOL; 5 CHLORO 2 [2 CHLORO 4 [(PHENYLAMINO)METHYL]PHENOXY]PHENOL; 5 [(4 BUTYL 1H 1,2,3 TRIAZOL 1 YL)METHYL] 2 (2,4 DICHLOROPHENOXY)PHENOL; 5 [(CYCLOHEXYLAMINO)METHYL] 2 (2,4 DICHLOROPHENOXY)PHENOL; ENOYL ACYL CARRIER PROTEIN REDUCTASE (NADH); TRICLOSAN; UNCLASSIFIED DRUG; [4 (2,4 DICHLOROPHENOXY) 3 HYDROXYPHENYL](MORPHOLIN 4 YL)METHANONE; [4 (2,4 DICHLOROPHENOXY) 3 HYDROXYPHENYL](PHENYL)METHANONE;

EID: 84879779979     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.201300050     Document Type: Article
Times cited : (19)

References (77)
  • 15
    • 0028557012 scopus 로고
    • S. Smith, FASEB J. 1994, 8, 1248-1259.
    • (1994) FASEB J. , vol.8 , pp. 1248-1259
    • Smith, S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.